Literature DB >> 32383060

ICU capacity management during the COVID-19 pandemic using a process simulation.

Andres Alban1, Stephen E Chick2,3, Dave A Dongelmans4, Alexander P J Vlaar4, Danielle Sent5.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32383060      PMCID: PMC7203503          DOI: 10.1007/s00134-020-06066-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
Dear Editor, Hospitals around the world are innovating their processes to separate COVID-19 patients from non-COVID-19 patients. Intensive care unit (ICU) capacity for COVID-19 patients has been expanded by converting post-anaesthesia care units (PACUs) into ICU, medical tents, deployment of care providers from OR to ICU, and numerous other innovations across geographies. Further capacity has been enabled by rescheduling non-urgent elective surgeries or, more generally, from learnings from prior reports following an influenza epidemic [1]. Epidemic models that describe how to ‘flatten the curve’ with public health initiatives are focused on the demand for care services. We have developed a simple patient simulation model (called icu-covid-sim) which explores the supply side: it supports hospital and regional planning decisions to ‘raise the bar’ with ICU capacity expansion activities and have deployed it on the web for others to use. The need for such a tool customized to support local and regional decision-making is highlighted by the high variability of critical care bed numbers across geographies [2]. The icu-covid-sim tool uses queueing theory and patient flow simulations [3]. It describes the maximum rate of COVID-19 patients which can be handled for a given number of ICU beds dedicated to COVID-19 patients, as a function of the arrival rate of COVID-19 patients, their length of stay (LOS) distribution, and the number of ICU beds dedicated to COVID-19 patients. We used the tool in analysing the acceptable flow rates at the Amsterdam UMC (location AMC). Figure 1 shows the output for a range of ICU bed sizes for COVID-19 patients. The maximum average throughput of COVID-19 patients might be less than the average arrival rate due to bed blocking associated with randomness in the arrival times and LOS of each patient. From the figure, for example, we can see that with 60 COVID-19 ICU beds, approximately 5.5 COVID-19 patients/day can make it through if 6.0 such patients/day arrive. The other patients would need to be referred to another facility due to bed blocking, at that capacity.
Fig. 1

Average throughput rate in long term of COVID patients per day as a function of the arrival rate and bed capacity. Throughput is the number of patients per day that can go through the system. Patient throughput rates would equal the patient arrival rates (the diagonal dotted line) if all patients were to be admitted to the ICU but is less than the arrival rate due to bed blocking. The star represents an example under 60 available beds where approximately 5.424 COVID-19 patients/day can go through if 6.0 such patients/day arrive. The bars represent stochastic variation over a simulated 3-month duration of a pandemic

Average throughput rate in long term of COVID patients per day as a function of the arrival rate and bed capacity. Throughput is the number of patients per day that can go through the system. Patient throughput rates would equal the patient arrival rates (the diagonal dotted line) if all patients were to be admitted to the ICU but is less than the arrival rate due to bed blocking. The star represents an example under 60 available beds where approximately 5.424 COVID-19 patients/day can go through if 6.0 such patients/day arrive. The bars represent stochastic variation over a simulated 3-month duration of a pandemic Supplementary material [4] provides additional background for the conceptual model and analysis, and web links below provide source code, a user guide, and a publicly available web-based implementation of the model. Analysis also includes graphs with the percent utilization of those beds. Similar statistics are provided for non-COVID ICU bed capacity decisions. The graphs were computed assuming a LOS distributed for COVID-19 patients from Wuhan data [5], and with Amsterdam ICU data for non-COVIDs. The tool allows for hospitals to enter their own arrival rate and LOS distributions. At a hospital level, the tool can inform decisions about how many COVID-19 patients can be handled. At a regional level, one might envisage using the tools for regional hospitals to compute how many referrals to a central hospital might be anticipated, for any given demand level for COVID-19 ICU resources. The icu-covid-sim tool is deployed at https://andres-alban.shinyapps.io/icu-covid-sim/ and source code and further modelling and usage details are available at https://github.com/sechick/icu-covid-sim/. See also [4]. Below is the link to the electronic supplementary material. Supplementary file1 (DOCX 13 kb)
  4 in total

1.  The variability of critical care bed numbers in Europe.

Authors:  A Rhodes; P Ferdinande; H Flaatten; B Guidet; P G Metnitz; R P Moreno
Journal:  Intensive Care Med       Date:  2012-07-10       Impact factor: 17.440

2.  ICU capacity management during the COVID-19 pandemic using a process simulation.

Authors:  Andres Alban; Stephen E Chick; Dave A Dongelmans; Alexander P J Vlaar; Danielle Sent
Journal:  Intensive Care Med       Date:  2020-05-07       Impact factor: 17.440

Review 3.  Recommendations for intensive care unit and hospital preparations for an influenza epidemic or mass disaster: summary report of the European Society of Intensive Care Medicine's Task Force for intensive care unit triage during an influenza epidemic or mass disaster.

Authors:  Charles L Sprung; Janice L Zimmerman; Michael D Christian; Gavin M Joynt; John L Hick; Bruce Taylor; Guy A Richards; Christian Sandrock; Robert Cohen; Bruria Adini
Journal:  Intensive Care Med       Date:  2010-02-05       Impact factor: 17.440

4.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

  4 in total
  15 in total

1.  Global Current Practices of Ventilatory Support Management in COVID-19 Patients: An International Survey.

Authors:  Jaber S Alqahtani; Renata G Mendes; Abdulelah Aldhahir; Daniel Rowley; Mohammed D AlAhmari; George Ntoumenopoulos; Saeed M Alghamdi; Jithin K Sreedharan; Yousef S Aldabayan; Tope Oyelade; Ahmed Alrajeh; Carlo Olivieri; Maher AlQuaimi; Jerome Sullivan; Mohammed A Almeshari; Antonio Esquinas
Journal:  J Multidiscip Healthc       Date:  2020-11-18

Review 2.  Considerations for acute care staffing during a pandemic.

Authors:  Niels Holthof; Markus M Luedi
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2020-12-10

3.  ICU capacity management during the COVID-19 pandemic using a process simulation.

Authors:  Andres Alban; Stephen E Chick; Dave A Dongelmans; Alexander P J Vlaar; Danielle Sent
Journal:  Intensive Care Med       Date:  2020-05-07       Impact factor: 17.440

4.  Pricing the COVID-19 vaccine: A mathematical approach.

Authors:  Susan E Martonosi; Banafsheh Behzad; Kayla Cummings
Journal:  Omega       Date:  2021-03-25       Impact factor: 7.084

5.  Supporting the Quadruple Aim Using Simulation and Human Factors During COVID-19 Care.

Authors:  Ambrose H Wong; Rami A Ahmed; Jessica M Ray; Humera Khan; Patrick G Hughes; Christopher Eric McCoy; Marc A Auerbach; Paul Barach
Journal:  Am J Med Qual       Date:  2021 Mar-Apr 01       Impact factor: 1.200

6.  How do we share data in COVID-19 research? A systematic review of COVID-19 datasets in PubMed Central Articles.

Authors:  Xu Zuo; Yong Chen; Lucila Ohno-Machado; Hua Xu
Journal:  Brief Bioinform       Date:  2021-03-22       Impact factor: 11.622

7.  Simulation of the COVID-19 patient flow and investigation of the future patient arrival using a time-series prediction model: a real-case study.

Authors:  Mahdieh Tavakoli; Reza Tavakkoli-Moghaddam; Reza Mesbahi; Mohssen Ghanavati-Nejad; Amirreza Tajally
Journal:  Med Biol Eng Comput       Date:  2022-02-12       Impact factor: 3.079

8.  Effects of Quarantine Disobedience and Mobility Restrictions on COVID-19 Pandemic Waves in Dynamical Networks.

Authors:  Dorian Stipic; Mislav Bradac; Tomislav Lipic; Boris Podobnik
Journal:  Chaos Solitons Fractals       Date:  2021-06-23       Impact factor: 5.944

Review 9.  Managing ICU surge during the COVID-19 crisis: rapid guidelines.

Authors:  Shadman Aziz; Yaseen M Arabi; Waleed Alhazzani; Laura Evans; Giuseppe Citerio; Katherine Fischkoff; Jorge Salluh; Geert Meyfroidt; Fayez Alshamsi; Simon Oczkowski; Elie Azoulay; Amy Price; Lisa Burry; Amy Dzierba; Andrew Benintende; Jill Morgan; Giacomo Grasselli; Andrew Rhodes; Morten H Møller; Larry Chu; Shelly Schwedhelm; John J Lowe; Du Bin; Michael D Christian
Journal:  Intensive Care Med       Date:  2020-06-08       Impact factor: 41.787

10.  Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.

Authors: 
Journal:  Intensive Care Med       Date:  2020-10-29       Impact factor: 41.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.